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Dear Editor,
Kim et al. reviewed potential therapeutic approaches against coronavirus diseases 2019 
(COVID-19) [1]. We would like to propose that vitamin C should also be included as a possible 
treatment as it has numerous effects on the immune system [2, 3].
In a meta-analysis of 29 controlled trials with 11,306 participants, we showed that regular 
vitamin C intake of around 1 g/day did not prevent upper respiratory tract infections (URTIs) 
[4]. However, the same trials found that vitamin C shortened and alleviated URTIs that 
occurred during the period of vitamin C administration. In adults the duration of infections 
was reduced by 8% and in children by 14% [4]. Given the low frequency and usually mild 
symptoms of URTIs, and the relatively small benefit, prophylactic daily vitamin C dosing 
does not seem worthwhile under normal circumstances. However, noting that many URTIs 
are caused by endemic coronaviruses, there is no reason or evidence to assume that vitamin C 
would be completely ineffective against COVID-19. Given that COVID-19 is often much more 
severe than ordinary URTIs, the above estimates might justify a regular increased daily intake 
of vitamin C while the prevalence of COVID-19 is high.
Furthermore, one of the major causes for concern with COVID-19 is the relatively high 
proportion of cases requiring intensive care unit (ICU) treatment. A meta-analysis of 12 trials 
with 1,766 patients in ICU found that vitamin C shortened ICU stay by 8% [5]. Another meta-
analysis of eight trials found that vitamin C shortened the duration of mechanical ventilation 
in patients who required the longest ventilation [6]. There is evidence that vitamin C levels 
decline dramatically in critically ill patients [5, 7]. Although 0.1 g/day of vitamin C can 
maintain a normal plasma level in a healthy person [8], much higher doses (1 – 4 g/day) are 
needed to increase plasma vitamin C levels of critically ill patients to within the normal range 
[5, 9]. Vitamin C is a safe and inexpensive essential nutrient and therefore investigation of 
its possible effects on COVID-19 should be encouraged along with the several other potential 
treatments [1].
Infect Chemother. 2020 Jun;52(2):222-223
https://doi.org/10.3947/ic.2020.52.2.222
pISSN 2093-2340·eISSN 2092-6448
Correspondence
Received: May 7, 2020
Accepted: May 9, 2020
Corresponding Author: 
Harri Hemilä, MD, PhD
Tukholmankatu 8B, Department of Public 
Health, University of Helsinki, POB 41, Helsinki, 
FI-00014, Finland.
E-mail: harri.hemila@helsinki.fi
Copyright © 2020 by The Korean Society 
of Infectious Diseases, Korean Society for 
Antimicrobial Therapy, and The Korean Society 
for AIDS
This is an Open Access article distributed 
under the terms of the Creative Commons 
Attribution Non-Commercial License (https://
creativecommons.org/licenses/by-nc/4.0/) 
which permits unrestricted non-commercial 
use, distribution, and reproduction in any 
medium, provided the original work is properly 
cited.
ORCID iDs
Harri Hemilä 
https://orcid.org/0000-0002-4710-307X
Elizabeth Chalker 
https://orcid.org/0000-0003-1593-3770
Conflict of Interest
No conflicts of interest.
Author Contributions
Conceptualization: HH, EC. Writing - original 
draft: HH. Writing - review & editing: HH, EC.
Harri Hemilä  1 and Elizabeth Chalker  2
1Department of Public Health, University of Helsinki, Helsinki, Finland
2School of Public Health, University of Sydney, Sydney, Australia
Vitamin C as a Possible Therapy for 
COVID-19
► See the article “Interim Guidelines on Antiviral Therapy for COVID-19” in volume 52 on page 281.
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